| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13630* | 2021 |
| Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium IG McKeith, BF Boeve, DW Dickson, G Halliday, JP Taylor, D Weintraub, ... Neurology 89 (1), 88-100, 2017 | 3801 | 2017 |
| Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies JR Mazzulli, YH Xu, Y Sun, AL Knight, PJ McLean, GA Caldwell, ... Cell 146 (1), 37-52, 2011 | 1461 | 2011 |
| Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease TF Outeiro, E Kontopoulos, SM Altmann, I Kufareva, KE Strathearn, ... science 317 (5837), 516-519, 2007 | 1289 | 2007 |
| Exosomal cell-to-cell transmission of alpha synuclein oligomers KM Danzer, LR Kranich, WP Ruf, O Cagsal-Getkin, AR Winslow, L Zhu, ... Molecular neurodegeneration 7, 1-18, 2012 | 953 | 2012 |
| Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy TL Spires, M Meyer-Luehmann, EA Stern, PJ McLean, J Skoch, ... Journal of Neuroscience 25 (31), 7278-7287, 2005 | 650 | 2005 |
| Hsp70 reduces α-synuclein aggregation and toxicity J Klucken, Y Shin, E Masliah, BT Hyman, PJ McLean Journal of Biological Chemistry 279 (24), 25497-25502, 2004 | 638 | 2004 |
| Formation of toxic oligomeric α-synuclein species in living cells TF Outeiro, P Putcha, JE Tetzlaff, R Spoelgen, M Koker, F Carvalho, ... PloS one 3 (4), e1867, 2008 | 535 | 2008 |
| Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration B Mollenhauer, V Cullen, I Kahn, B Krastins, TF Outeiro, I Pepivani, J Ng, ... Experimental neurology 213 (2), 315-325, 2008 | 452 | 2008 |
| Distinct roles in vivo for the ubiquitin–proteasome system and the autophagy–lysosomal pathway in the degradation of α-synuclein D Ebrahimi-Fakhari, I Cantuti-Castelvetri, Z Fan, E Rockenstein, ... Journal of Neuroscience 31 (41), 14508-14520, 2011 | 444 | 2011 |
| Double-blind trial of imipramine in Alzheimer’s disease patients with and without depression BV Reifler, L Teri, M Raskind, R Veith, R Barnes, E White, P McLean Am J Psychiatry 146 (1), 45-9, 1989 | 427 | 1989 |
| Targeted overexpression of human α-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease S Theodore, S Cao, PJ McLean, DG Standaert Journal of Neuropathology & Experimental Neurology 67 (12), 1149-1158, 2008 | 420 | 2008 |
| α‐Synuclein oligomers and clinical implications for Parkinson disease LV Kalia, SK Kalia, PJ McLean, AM Lozano, AE Lang Annals of neurology 73 (2), 155-169, 2013 | 410 | 2013 |
| The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates α-synuclein degradation decisions between proteasomal and lysosomal pathways Y Shin, J Klucken, C Patterson, BT Hyman, PJ McLean Journal of Biological Chemistry 280 (25), 23727-23734, 2005 | 403 | 2005 |
| TorsinA and heat shock proteins act as molecular chaperones: suppression of α‐synuclein aggregation PJ McLean, H Kawamata, S Shariff, J Hewett, N Sharma, K Ueda, ... Journal of neurochemistry 83 (4), 846-854, 2002 | 403 | 2002 |
| Heat-shock protein 70 modulates toxic extracellular α-synuclein oligomers and rescues trans-synaptic toxicity KM Danzer, WP Ruf, P Putcha, D Joyner, T Hashimoto, C Glabe, ... The FASEB journal 25 (1), 326, 2011 | 384 | 2011 |
| Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington’s and Parkinson’s diseases RA Bodner, TF Outeiro, S Altmann, MM Maxwell, SH Cho, BT Hyman, ... Proceedings of the National Academy of Sciences 103 (11), 4246-4251, 2006 | 350 | 2006 |
| Membrane association and protein conformation of α-synuclein in intact neurons: effect of Parkinson′ s disease-linked mutations PJ McLean, H Kawamata, S Ribich, BT Hyman Journal of Biological Chemistry 275 (12), 8812-8816, 2000 | 335 | 2000 |
| Protein degradation pathways in Parkinson’s disease: curse or blessing D Ebrahimi-Fakhari, L Wahlster, PJ McLean Acta neuropathologica 124, 153-172, 2012 | 310 | 2012 |
| Alpha-synuclein and tau: teammates in neurodegeneration? S Moussaud, DR Jones, EL Moussaud-Lamodière, M Delenclos, OA Ross, ... Molecular neurodegeneration 9, 1-14, 2014 | 305 | 2014 |
Jochen KluckenUniversity of Luxembourg, Centre Hospitalier du LuxembourgBestätigte E-Mail-Adresse bei uni.lu
